ABHD12B
Protein ABHD12B
Also known as: AB12B_HUMAN, BEM46L3, C14orf29
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z5M8
- Gene
- ABHD12B
- Ensembl
- ENSG00000131969
- Chromosome
- 14
- Canonical length
- 362 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable lysophospholipase activity and monoacylglycerol lipase activity. Predicted to be involved in monoacylglycerol catabolic process and phosphatidylserine catabolic process. Predicted to be active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>Q7Z5M8|ABHD12B
1 MDAQDCQAAA SPEPPGPPAR SCVAAWWDMV DRNLRYFPHS CSMLGRKIAA LYDSFTSKSL
61 KEHVFLPLID MLIYFNFFKA PFLVDLKKPE LKIPHTVNFY LRVEPGVMLG IWHTVPSCRG
121 EDAKGKDCCW YEAALRDGNP IIVYLHGSAE HRAASHRLKL VKVLSDGGFH VLSVDYRGFG
181 DSTGKPTEEG LTTDAICVYE WTKARSGITP VCLWGHSLGT GVATNAAKVL EEKGCPVDAI
241 VLEAPFTNMW VASINYPLLK IYRNIPGFLR TLMDALRKDK IIFPNDENVK FLSSPLLILH
301 GEDDRTVPLE YGKKLYEIAR NAYRNKERVK MVIFPPGFQH NLLCKSPTLL ITVRDFLSKQ
361 WSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD12B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- retina: 13 nTPM
- skin: 9.8 nTPM
- basal ganglia: 6.3 nTPM
- cerebral cortex: 2.3 nTPM
- bone marrow: 1.3 nTPM
- breast: 1.1 nTPM
Single-cell type
- müller glia: 234 nCPM
- adipocytes: 64 nCPM
- epicardial cells: 64 nCPM
- rod photoreceptor cells: 53 nCPM
- oocytes: 41 nCPM
- respiratory ciliated cells: 31 nCPM
Immune cell
- neutrophil: 2.2 nTPM
- eosinophil: 1 nTPM
- basophil: 0.3 nTPM
- classical monocyte: 0.3 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 20 nTPM
- basal ganglia: 20 nTPM
- midbrain: 17 nTPM
- amygdala: 12 nTPM
- cerebral cortex: 11 nTPM
- hypothalamus: 8.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.58
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.17
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD12B as an antibody target. Whether an autoantibody or antibody against ABHD12B could matter depends on whether native ABHD12B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD12B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABHD12B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...